Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 8, 2015

View Archived Issues

Sanofi compares SAR-366234 to latanoprost in patients with glaucoma or ocular hypertension

FDA gives orphan drug status to udenafil for the treatment single ventricle congenital heart disease

Wistar Institute and Spark Therapeutics to study liver-directed gene therapy vectors

Nivolumab gets FDA orphan drug designation for the treatment of HCC

AstraZeneca licenses Starpharma's dendrimer-based drug delivery technology

Caenorhabditis elegans used to model weight gain resulting from antipsychotic use

Cellectis and MD Anderson Cancer Center form collaboration for liquid tumor immunotherapy

OICR and SGC investigators make OICR-9429 available to research community

Cytori stem cell therapy ECCS-50 enters phase III trial in male urinary incontinence

Protalex set to open enrollment in phase I/II study of PRTX-100 for ITP

VCP-746, a cardioprotective adenosine receptor agonist

Basilea Pharmaceutica's BAL-30072 will be part of European iABC program

Cipla EU to acquire two generic businesses in U.S.

Pfizer acquires Hospira

Novel SLC22A5 gene mutation linked to ADHD

Vernalis launches Tuzistra XR in U.S.

Piramal discloses GPR120 agonists

Bristol-Myers Squibb introduces new HIV integrase inhibitors

Novita Pharmaceuticals and Cornell University report fascin inhibitors

Roche patents V1a receptor antagonists

Debiopharm and Solid Biosciences collaborate to investigate alisporivir in DMD

Novel BET inhibitors designed for treating brain cancer

Achillion presents complement factor D inhibitors

European ADAPT SMART initiative launched to improve efficiency in drug development

Second unsolicited offer to acquire InSite Vision deemed superior to QLT's amended proposal

Phase I results for carfilzomib-vorinostat combination in relapsed or refractory B-cell lymphomas

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...